BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND RET, RET51, 5979, P07949, ENSG00000165731, MTC1, MEN2A, RET-ELE1, HSCR1, MEN2B, CDHF12 AND Prognosis
9 results:

  • 1. Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo.
    Spohr C; Poggio T; Andrieux G; Schönberger K; Cabezas-Wallscheid N; Boerries M; Halbach S; Illert AL; Brummer T
    Leukemia; 2022 Apr; 36(4):970-982. PubMed ID: 34903841
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Second Malignancies after Radiation Therapy: Update on Pathogenesis and Cross-sectional Imaging Findings.
    Khanna L; Prasad SR; Yedururi S; Parameswaran AM; Marcal LP; Sandrasegaran K; Tirumani SH; Menias CO; Katabathina VS
    Radiographics; 2021; 41(3):876-894. PubMed ID: 33891523
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid leukemia: A PETHEMA Study.
    Rodríguez-Arbolí E; Martínez-Cuadrón D; Rodríguez-Veiga R; Carrillo-Cruz E; Gil-Cortés C; Serrano-López J; Bernal Del Castillo T; Martínez-Sánchez MDP; Rodríguez-Medina C; Vidriales B; Bergua JM; Benavente C; García-Boyero R; Herrera-Puente P; Algarra L; Sayas-Lloris MJ; Fernández R; Labrador J; Lavilla-Rubira E; Barrios-García M; Tormo M; Serrano-Maestro A; Sossa-Melo CL; García-Belmonte D; Vives S; Rodríguez-Gutiérrez JI; Albo-López C; Garrastazul-Sánchez MP; Colorado-Araujo M; Mariz J; Sanz MÁ; Pérez-Simón JA; Montesinos P;
    Transplant Cell Ther; 2021 Apr; 27(4):311.e1-311.e10. PubMed ID: 33836871
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A 9‑lncRNA risk score system for predicting the prognosis of patients with hepatitis B virus‑positive hepatocellular carcinoma.
    Liu H; Zhao P; Jin X; Zhao Y; Chen Y; Yan T; Wang J; Wu L; Sun Y
    Mol Med Rep; 2019 Jul; 20(1):573-583. PubMed ID: 31115573
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cytogenetics in the management of Philadelphia-negative myeloproliferative neoplasms: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
    Bilhou-Nabéra C; Bidet A; Eclache V; Lippert E; Mozziconacci MJ
    Ann Biol Clin (Paris); 2016 Oct; 74(5):517-523. PubMed ID: 27477946
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Thyroid carcinoma in children, adolescents and adults, both spontaneous and after childhood radiation exposure.
    Ho WL; Zacharin MR
    Eur J Pediatr; 2016 May; 175(5):677-83. PubMed ID: 26805408
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.
    Coenen EA; Zwaan CM; Reinhardt D; Harrison CJ; Haas OA; de Haas V; Mihál V; De Moerloose B; Jeison M; Rubnitz JE; Tomizawa D; Johnston D; Alonzo TA; Hasle H; Auvrignon A; Dworzak M; Pession A; van der Velden VH; Swansbury J; Wong KF; Terui K; Savasan S; Winstanley M; Vaitkeviciene G; Zimmermann M; Pieters R; van den Heuvel-Eibrink MM
    Blood; 2013 Oct; 122(15):2704-13. PubMed ID: 23974201
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A pilot characterization of human lung NSCLC by protein pathway activation mapping.
    Zupa A; Improta G; Silvestri A; Pin E; Deng J; Aieta M; Musto P; Nitti D; Mammano E; Liotta L; Belluco C; Wulfkuhle J; Petricoin E
    J Thorac Oncol; 2012 Dec; 7(12):1755-1766. PubMed ID: 23154546
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.
    Smith CC; Wang Q; Chin CS; Salerno S; Damon LE; Levis MJ; Perl AE; Travers KJ; Wang S; Hunt JP; Zarrinkar PP; Schadt EE; Kasarskis A; Kuriyan J; Shah NP
    Nature; 2012 Apr; 485(7397):260-3. PubMed ID: 22504184
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.